The IGF1 titration group had lower IGF1 levels after 2 years of the trial ( mean 1.16 , s.d. 1.24 ) compared with both the low-dose ( mean 1.76 , s.d. 1.48 ) and the high-dose ( mean 2.97 , s.d. 1.63 ) groups .